Meanwhile, tumor-derived exosomes (TDEs) play a pivotal role in reorienting TAMs towards an immunosuppressive, glycolytic-dominant metabolic phenotype, a process orchestrated through the TLR2 and NF-κB pathway. Here, NFKB1 is linked to neoplasm.